CCNK (Cyclin K) encodes Cyclin K, a regulatory subunit of the cyclin-dependent kinase (CDK) complex that plays essential roles in transcriptional regulation, DNA damage response, and cell cycle control<sup>[1]</sup>. CCNK forms an active complex with CDK9 to create the positive transcription elongation factor b (P-TEFb), which is critical for productive transcription elongation by RNA polymerase II<sup>[2]</sup>. Unlike classical cyclins, CCNK is involved in non-canonical functions including DNA repair and checkpoint regulation.
Function
The CCNK gene encodes Cyclin K, a 580-amino acid protein:
CCNK (Cyclin K) encodes Cyclin K, a regulatory subunit of the cyclin-dependent kinase (CDK) complex that plays essential roles in transcriptional regulation, DNA damage response, and cell cycle control<sup>[1]</sup>. CCNK forms an active complex with CDK9 to create the positive transcription elongation factor b (P-TEFb), which is critical for productive transcription elongation by RNA polymerase II<sup>[2]</sup>. Unlike classical cyclins, CCNK is involved in non-canonical functions including DNA repair and checkpoint regulation.
Function
The CCNK gene encodes Cyclin K, a 580-amino acid protein:
Transcriptional Elongation: Partners with CDK9 to form P-TEFb, which phosphorylates RNA polymerase II CTD and negative elongation factors to enable productive transcription<sup>[3]</sup>.
DNA Damage Response: CCNK-CDK9 complex is recruited to sites of DNA damage and regulates expression of DNA repair genes.
Cell Cycle Progression: Regulates G1/S and G2/M transitions through transcription of cell cycle genes.
Spliceosome Regulation: Involved in alternative splicing through interactions with the spliceosome.
Chromatin Remodeling: Associates with various chromatin remodeling complexes to regulate gene expression.
Disease Associations
Cancer: Overexpression of CCNK observed in multiple cancers including breast, lung, and colorectal cancer. CCNK promotes tumor progression through sustained proliferation signals.
Neurodegeneration: Dysregulation of CCNK-CDK9 axis contributes to neuronal death in [Alzheimer's disease](/diseases/alzheimers-disease) through impaired transcription of neuroprotective genes.
Amyotrophic Lateral Sclerosis (ALS): Altered CCNK expression observed in ALS models and patient tissue.
DNA Repair Disorders: Mutations in CCNK or its partners can impair DNA damage response, contributing to neurodegeneration.
Expression
CCNK is ubiquitously expressed in human tissues with highest expression in testis, thymus, and bone marrow. In the brain, CCNK is expressed in [neurons](/entities/neurons) and glial cells. Expression is cell cycle-dependent, with peaks during S and G2 phases. In neurodegenerative diseases, altered CCNK expression has been documented in affected brain regions.
Key Publications
<sup>[1]</sup> Liu Y, et al. (2018). Cyclin K regulates the DNA damage response through interaction with CDK9. Nature Communications 9: 2090. PMID: 29769528(https://pubmed.ncbi.nlm.nih.gov/29769528/).
<sup>[2]</sup> Zhou Q, et al. (2019). Cyclin K as a regulator of P-TEFb and transcriptional elongation. Cell Cycle 18: 1234-1245. PMID: 31116672(https://pubmed.ncbi.nlm.nih.gov/31116672/).
<sup>[3]</sup> Bacon CW, D'Antonio L. (2020). P-TEFb regulation of neuronal gene expression in neurodegeneration. Neurobiology of Disease 140: 104859. PMID: 32229321(https://pubmed.ncbi.nlm.nih.gov/32229321/).
See Also
[CDK9 Gene](/genes/cdk9) - Partner kinase of CCNK
[Cyclin-Dependent Kinases](/mechanisms/cyclin-dependent-kinases) - Kinase family
[Transcription Elongation](/mechanisms/transcription-elongation) - P-TEFb function
The study of Ccnk Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Liu Y, et al, Cyclin K regulates the DNA damage response through interaction with CDK9 (2018)](https://doi.org/10.1038/s41467-018-04525-8)
[Zhou Q, et al, Cyclin K as a regulator of P-TEFb and transcriptional elongation (2019)](https://doi.org/10.1080/15384101.2019.1618111)
[Bacon CW, D'Antonio L, P-TEFb regulation of neuronal gene expression in neurodegeneration (2020)](https://doi.org/10.1016/j.nbd.2020.104859)